Diagnostic performance of loop-mediated isothermal amplification (LAMP) and antigen test in comparison with reverse transcriptase-polymerization chain reactioin (RT-PCR) for detection of SARS-CoV-2 among patients presenting with COVID-19 symptoms in Mwanza, Tanzania
Material type:
TextPublisher number: Wurzburg Road 35, BMC Premises, Post Code: 33102: P. O Box 1464, Mwanza – Tanzania: Phone: +255 28 298 3384: Fax: +255 28 298 3386 Email: vc@bugando.ac.tz Website: www.bugando.ac.tz Language: English Publication details: Mwanza, Tanzania: Catholic University of Health and Allied Sciences [CUHAS – Bugando] : 2022Description: 62 Pages; Includes References and AppendicesSubject(s): Summary: Abstract:
Background: The Coronavirus diseases 2019 (COVID-19) pandemic which is caused by severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) reported for the first time in Wuhan, China in December 2019 and spread out all over the world. It has become not only a major health problem but also an economic and social problem. Because of the high global demand for SARS-CoV-2 test kits, the development and production of rapid test kits by various manufacturers in the world have rapidly scaled up with limited performance data from low- and middle-income countries (LMICs). The aim of this study was to compare the performance of antigen test with reverse transcriptase-polymerase chain reaction (RTPCR) for the detection of SARS-CoV-2 and determine the best duration of symptom onset for using AgRDT.
Methods: This cross-sectional study involved 503 samples conducted in Mwanza between May and August 2022. Demographic data and symptoms associated with SARS-CoV-2 infection were collected from COVID-19 investigation forms. Antigen rapid diagnostic test (Ag-RDT) was used to detect the presence of nucleocapsid protein antigen of the SARS-CoV-2 from nasal swabs specimens of the patients after RT-PCR assay as the gold standard. The data obtained were summarized in excel and analysed by using STATA 15.
Results: Out of 503 samples, 98 (20%) tested positive for both RT-PCR and Ag-RDT, 379 (75%) tested negative for both RT-PCR and Ag-RDT, and 26 (5%) samples had discordant results of RT-PCR positive and Ag-RDT negative. The overall diagnostic performance of Ag-RDT showed 79.03% sensitivity and 100% specificity. Ag- RDT show near-perfect agreement with RT-PCR with the value of 94.83% vs 65.47%. The Ag-RDT was more sensitive on the first four days of symptoms onset of COVID-19 with the sensitivity of 80.7% observed for a COVID-19 presumptive with cough and 87.1% for a COVID-19 presumptive with a combination of cough and fever.
Conclusion: The promising performance of Ag-RDT renders it useful as a screening tool alongside RTPCR to reduce transmission through improving contact tracing, implementation of local mitigation strategies, and refining existing testing protocol for diagnosis of COVID-19. Performing Ag-RDT, in early stages of SARS-CoV-2 infections in the presence of cough and fever significantly increase the sensitivity of the test.
| Item type | Current library | Collection | Copy number | Status | Barcode | |
|---|---|---|---|---|---|---|
| POSTGRADUATE DISSERTATIONS | MWALIMU NYERERE LEARNING RESOURCES CENTRE-CUHAS BUGANDO | NFIC | CREC/571/2022 | 1 | CREC/571/2022 |
Abstract:
Background: The Coronavirus diseases 2019 (COVID-19) pandemic which is caused by severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) reported for the first time in Wuhan, China in December 2019 and spread out all over the world. It has become not only a major health problem but also an economic and social problem. Because of the high global demand for SARS-CoV-2 test kits, the development and production of rapid test kits by various manufacturers in the world have rapidly scaled up with limited performance data from low- and middle-income countries (LMICs). The aim of this study was to compare the performance of antigen test with reverse transcriptase-polymerase chain reaction (RTPCR) for the detection of SARS-CoV-2 and determine the best duration of symptom onset for using AgRDT.
Methods: This cross-sectional study involved 503 samples conducted in Mwanza between May and August 2022. Demographic data and symptoms associated with SARS-CoV-2 infection were collected from COVID-19 investigation forms. Antigen rapid diagnostic test (Ag-RDT) was used to detect the presence of nucleocapsid protein antigen of the SARS-CoV-2 from nasal swabs specimens of the patients after RT-PCR assay as the gold standard. The data obtained were summarized in excel and analysed by using STATA 15.
Results: Out of 503 samples, 98 (20%) tested positive for both RT-PCR and Ag-RDT, 379 (75%) tested negative for both RT-PCR and Ag-RDT, and 26 (5%) samples had discordant results of RT-PCR positive and Ag-RDT negative. The overall diagnostic performance of Ag-RDT showed 79.03% sensitivity and 100% specificity. Ag- RDT show near-perfect agreement with RT-PCR with the value of 94.83% vs 65.47%. The Ag-RDT was more sensitive on the first four days of symptoms onset of COVID-19 with the sensitivity of 80.7% observed for a COVID-19 presumptive with cough and 87.1% for a COVID-19 presumptive with a combination of cough and fever.
Conclusion: The promising performance of Ag-RDT renders it useful as a screening tool alongside RTPCR to reduce transmission through improving contact tracing, implementation of local mitigation strategies, and refining existing testing protocol for diagnosis of COVID-19. Performing Ag-RDT, in early stages of SARS-CoV-2 infections in the presence of cough and fever significantly increase the sensitivity of the test.
There are no comments on this title.
Click on an image to view it in the image viewer